The Leadership Team at Engitix Therapeutics guides the strategic direction and vision of the company, leveraging their expertise in therapeutics and scientific innovation. Comprised of the CEO & Co-founder, Chief Scientific Officer, and Vice President of Fibrosis, this team drives the development of ECM-based therapies to address life-threatening diseases, ensuring alignment between research initiatives and market needs while fostering a collaborative culture.